IN188000B - - Google Patents

Info

Publication number
IN188000B
IN188000B IN361DE1998A IN188000B IN 188000 B IN188000 B IN 188000B IN 361DE1998 A IN361DE1998 A IN 361DE1998A IN 188000 B IN188000 B IN 188000B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Richard Tadao Matsuoka
Peng Liu
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IN188000B publication Critical patent/IN188000B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN361DE1998 1997-02-14 1998-02-12 IN188000B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3819697P 1997-02-14 1997-02-14

Publications (1)

Publication Number Publication Date
IN188000B true IN188000B (zh) 2002-08-03

Family

ID=21898590

Family Applications (1)

Application Number Title Priority Date Filing Date
IN361DE1998 IN188000B (zh) 1997-02-14 1998-02-12

Country Status (41)

Country Link
US (2) US6294675B1 (zh)
EP (1) EP0973769B1 (zh)
JP (1) JP4227671B2 (zh)
KR (1) KR100551667B1 (zh)
CN (1) CN1093128C (zh)
AP (1) AP1202A (zh)
AR (1) AR011126A1 (zh)
AT (1) ATE274511T1 (zh)
AU (1) AU730162B2 (zh)
BG (1) BG63970B1 (zh)
BR (1) BRPI9808642B8 (zh)
CA (1) CA2281471C (zh)
CO (1) CO4950549A1 (zh)
CY (1) CY2551B1 (zh)
CZ (1) CZ296543B6 (zh)
DE (1) DE69825880T2 (zh)
DK (1) DK0973769T3 (zh)
DZ (1) DZ2418A1 (zh)
EA (1) EA001761B1 (zh)
EG (1) EG23780A (zh)
ES (1) ES2224358T3 (zh)
HK (1) HK1026206A1 (zh)
HU (1) HU228098B1 (zh)
ID (1) ID23155A (zh)
IL (4) IL143784A (zh)
IN (1) IN188000B (zh)
MA (1) MA24472A1 (zh)
MY (1) MY120024A (zh)
NO (1) NO317761B1 (zh)
NZ (1) NZ337182A (zh)
OA (1) OA11086A (zh)
PE (1) PE59799A1 (zh)
PL (1) PL192837B1 (zh)
PT (1) PT973769E (zh)
SA (1) SA98190146B1 (zh)
SI (1) SI0973769T1 (zh)
SK (1) SK285125B6 (zh)
TR (1) TR199901935T2 (zh)
UA (1) UA57060C2 (zh)
WO (1) WO1998035962A1 (zh)
ZA (1) ZA981208B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR011126A1 (es) * 1997-02-14 2000-08-02 Smithkline Beecham Corp Procedimiento para preparar eprosartano y compuestos intermediarios.
US6630498B2 (en) * 1997-08-06 2003-10-07 Smithkline Beecham Corporation Eprosartan arginyl charge-neutralization-complex and a process for its preparation and formulation
IL140905A0 (en) * 1998-07-20 2002-02-10 Smithkline Beecham Corp Bioenhanced formulations comprising eprosartan in oral solid dosage form
US20060099230A1 (en) * 2004-11-10 2006-05-11 Chin-Chih Chiang Novel formulations of eprosartan with enhanced bioavailability
WO2008078330A1 (en) * 2006-12-27 2008-07-03 Hetero Drugs Limited Improved process for eprosartan
RU2453536C2 (ru) * 2007-10-22 2012-06-20 Оркид Рисерч Лабораториз Лимитед Ингибиторы гистондезацетилазы
CN101215284B (zh) * 2007-12-31 2010-10-13 浙江华海药业股份有限公司 一种改进的依普罗沙坦的制备方法
WO2011004384A2 (en) 2009-06-05 2011-01-13 Glochem Industries Limited Process for the preparation of eprosartan
CN102584709B (zh) * 2011-12-19 2016-08-17 浙江华海药业股份有限公司 一种改进的依普罗沙坦中间体芳基咪唑醛的制备工艺
CN103288742A (zh) * 2013-06-04 2013-09-11 四川百利药业有限责任公司 一种高纯度英加韦林原料的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
US5418250A (en) * 1989-06-14 1995-05-23 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
DE10075018I2 (de) * 1989-06-14 2001-08-09 Smithkline Beecham Corp Imidazoalkensäure.
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
EP0563238B1 (en) * 1990-12-14 2002-05-22 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
AR011126A1 (es) * 1997-02-14 2000-08-02 Smithkline Beecham Corp Procedimiento para preparar eprosartano y compuestos intermediarios.

Also Published As

Publication number Publication date
EP0973769A1 (en) 2000-01-26
NO317761B1 (no) 2004-12-13
US6294675B1 (en) 2001-09-25
DE69825880D1 (de) 2004-09-30
PL335074A1 (en) 2000-04-10
BR9808642A (pt) 2000-05-23
AP1202A (en) 2003-09-02
ATE274511T1 (de) 2004-09-15
CA2281471A1 (en) 1998-08-20
KR100551667B1 (ko) 2006-02-13
IL131310A (en) 2003-02-12
CN1093128C (zh) 2002-10-23
EA199900741A1 (ru) 2000-02-28
KR20000071008A (ko) 2000-11-25
SA98190146B1 (ar) 2006-08-20
PL192837B1 (pl) 2006-12-29
BRPI9808642B8 (pt) 2021-05-25
CY2551B1 (en) 2008-07-02
US20020028951A1 (en) 2002-03-07
IL143785A (en) 2004-12-15
CA2281471C (en) 2007-04-24
NO993912D0 (no) 1999-08-13
JP2001511808A (ja) 2001-08-14
SI0973769T1 (en) 2004-12-31
AR011126A1 (es) 2000-08-02
BG63970B1 (bg) 2003-08-29
IL131310A0 (en) 2001-01-28
CO4950549A1 (es) 2000-09-01
DE69825880T2 (de) 2005-09-08
IL143783A0 (en) 2002-04-21
NZ337182A (en) 2001-04-27
HUP0001813A3 (en) 2001-07-30
BG103649A (en) 2000-06-30
IL143783A (en) 2005-05-17
CN1247538A (zh) 2000-03-15
SK108699A3 (en) 2000-05-16
EG23780A (en) 2007-08-13
UA57060C2 (uk) 2003-06-16
PE59799A1 (es) 1999-08-06
DK0973769T3 (da) 2004-12-13
WO1998035962A1 (en) 1998-08-20
CZ285199A3 (cs) 2000-02-16
MY120024A (en) 2005-08-30
PT973769E (pt) 2004-11-30
AU6273298A (en) 1998-09-08
JP4227671B2 (ja) 2009-02-18
US6458963B1 (en) 2002-10-01
OA11086A (en) 2003-03-13
AU730162B2 (en) 2001-03-01
HK1026206A1 (en) 2000-12-08
ID23155A (id) 2000-03-23
EP0973769A4 (en) 2001-01-24
ZA981208B (en) 1998-11-12
HUP0001813A2 (hu) 2001-06-28
TR199901935T2 (xx) 1999-12-21
CZ296543B6 (cs) 2006-04-12
IL143784A0 (en) 2002-04-21
HU228098B1 (en) 2012-10-29
AP9901619A0 (en) 1999-09-30
SK285125B6 (sk) 2006-06-01
MA24472A1 (fr) 1998-10-01
ES2224358T3 (es) 2005-03-01
BR9808642B1 (pt) 2013-11-26
IL143784A (en) 2005-05-17
EP0973769B1 (en) 2004-08-25
EA001761B1 (ru) 2001-08-27
DZ2418A1 (fr) 2003-06-26
NO993912L (no) 1999-08-13
IL143785A0 (en) 2002-04-21

Similar Documents

Publication Publication Date Title
ITMI971385A0 (zh)
IN188000B (zh)
IN188498B (zh)
ITVI970050A0 (zh)
ECSDI970453S (zh)
GR1004743B (zh)
IN189776B (zh)
IN190579B (zh)
ITCH970006A0 (zh)
ITMI971291A0 (zh)
ITTO970106V0 (zh)
ITUD970096A0 (zh)
CN3057977S (zh)
CN3058923S (zh)
CN3057976S (zh)
CN3055123S (zh)
CN3057730S (zh)
CN3058984S (zh)
CN3057614S (zh)
CN3054902S (zh)
CN3057613S (zh)
CN3057436S (zh)
CN3057229S (zh)
CN3056875S (zh)
CN3056826S (zh)